Where's the Beef?

  • by: |
  • 01/18/2013

From the pages of Food Safety News:

Common Ground Exists in Drug Resistance Debate: Response to Pew Op-Ed

To some, the ongoing debate over the use of antibiotics in animals raised for food is like the sign post in the Wizard of Oz — pointing in opposite directions. But from reading “Antibiotics in Food Animal Production: Pew’s Response to Raymond Op-Ed,” Jan.11, there is violent agreement between PEW and the animal health industry.

Gail Hansen writes that Pew “opposes the use of antibiotics for growth promotion, but strongly supports their use to treat sick animals.” That’s radically similar to the position the animal health industry has taken on FDA’s timely and thoughtful effort to phase out growth promotion claims on medically important antibiotics and phase in veterinary oversight of these compounds.  This policy harmonizes antibiotics use in animals and humans and eliminates the use of antibiotics as growth promoters, similar to the European ban on antibiotic growth promoters.

FDA’s action ensures that medicines will now be used in animal health much the same way as they are used by humans – administered only to address disease and under the direction of a licensed medical professional.  This policy is the net result of what a number of public health advocacy groups, including Pew, called for in a 2009 letter to the White House.

On the issue of the amount of antibiotics used in animals, Hansen also acknowledges something the animal health industry has pointed out:  about 40 percent of the total compounds used in animal agriculture aren’t used in human medicine and don’t figure into the debate over antibiotic resistance. The focus on the amount used in animals vs. humans, according to Dr. Raymond, is a “distraction from the real truth.” I agree.

While the Danish ban on growth promoters – known as the Danish Experiment –has reduced some instances of resistance in animals, reductions and changes in use of antibiotics in animals have had no effect on rates of antibiotic resistance in humans. For example, after certain antibiotics in animal feed were banned in Denmark, a 2011 GAO Report stated, “Danish officials told us that Denmark’s resistance data have not shown a decrease in antibiotic resistance in humans after implementation of the various Danish policies, except for a few limited examples.”  Again, this appears to be another area where the animal health industry, Hansen and the GAO all agree. Wonderful!

Fact: Simply banning uses of antibiotics used to keep food animals healthy does not address the unrelated problem of antibiotic resistance in humans, but will certainly add to animal disease and suffering. The issue of antibiotic resistance is one that is both important and scientifically complex, and reliance on simplistic solutions will not solve the problem and may make it worse.

It does matter which direction we go and how we get there. I look forward to contributing to this importance discussion on the nexus between human and animal health.

Peter J. Pitts, a former FDA Associate Commissioner, is President of the Center for Medicine in the Public Interest and a member of the Animal Health Institute’s Board of Scientific Advisors 


Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog